{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1200.134","meta":{"versionId":"4","lastUpdated":"2020-11-22T07:02:48.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Cliniwiz Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2020-11-22"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1200.134","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1200.134"}],"version":"20201122","name":"ProthrombinTimeWithINR","title":"Prothrombin time with INR","status":"active","experimental":false,"date":"2020-11-22T07:02:48-05:00","publisher":"Cliniwiz Steward","description":"Reference Range\nPT\t9.0-11.5 sec\nINR\t \n  Reference range\t0.9-1.1\n  Moderate-intensity Warfarin therapy  2.0-3.0\n  Higher-intensity Warfarin therapy\t3.0-4.0","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"85610","display":"Prothrombin time"}]}]},"expansion":{"identifier":"urn:uuid:c898dc03-af9a-44d0-a383-e1c4f7a1a3c9","timestamp":"2023-12-10T23:14:12-05:00","total":1,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"85610","display":"Prothrombin time"}]}}